Panelist: Augusto Penjasoff Business Partner, Global Cell Therapy IT Head Bristol Myers Squibb
Panelist: Curt Fitzgerald Director - Service Delivery - Cell & Gene Therapy Novartis
Panelist: Gary Gabriel Global Advisor for Healthcare and Life Sciences, Tableau Salesforce
Panelist: Neary Detrick Senior Director, Enterprise Data Management & Analytics bluebird bio
Moderator: Beth Hayes Healthcare and Lifesciences Business Consulting - Pharma Lead Salesforce
For those working on potentially life-changing cell and gene therapies - whether developing the therapy itself, executing clinical trials, preparing to launch, manufacturing, or administering - the requirements of these complex and delicate value chains is something pharma has traditionally never seen before. Important data often owned by treatment centres, is needed by manufacturers to prepare capacity, by developers to engage payers and patients, as well as required by regulators for approval and post-marketing.
To achieve commercial success, there needs to be an established end-to-end data integration framework that enables the seamless onboarding of new treatment centres, CDMOs and capacity builders, reduces delivery costs through data insights, infuses patient insights and streamlines patient scheduling.
In this free to attend, live webinar, cell and gene IT and data analytics experts from Novartis, BMS, bluebird bio and Salesforce will share their lessons learned in innovating data sharing approaches and achieving multi-stakeholder alignment through data standardization and IT infrastructure readiness. You will learn how to:
Tune in live to join the Q&A with our panellists, or if you can’t make it live, sign up to pre-order your recording.